Breaking Down CNSIG Inner Mongolia Chemical Industry Co., Ltd. Financial Health: Key Insights for Investors

Investors parsing CNSIG Inner Mongolia Chemical Industry Co., Ltd. (600328.SS) will want to weigh a mixed financial picture: quarter revenue of 2.78 billion CNY (down 13.42% YoY) and trailing twelve-month revenue of 12.10 billion CNY (down 9.83% YoY) sit alongside a market capitalization of 12.15 billion CNY and a stock price of 8.40 CNY (as of Nov 28, 2025); profitability has slumped with gross profit margin at 16.02% and gross profit of 2.06 billion CNY (gross profit down 41.54% YoY), EBITDA of 2.04 billion CNY (EBITDA margin 15.85%, down 37.32% YoY), operating income of 1.02 billion CNY (operating margin 7.87%, down 54.19% YoY) and a dramatic net income decline to 57.83 million CNY for the nine months ended Sep 30, 2025 (compared with 573.99 million CNY a year earlier) yielding a TTM net income of 2.64 million CNY and TTM EPS of 0.00 CNY; valuation metrics show a startling trailing P/E of 4,320.02 and forward P/E of 41.21, with P/S at 1.00, P/B at 0.93 and EV/EBITDA of 6.43, while balance-sheet signals include an enterprise value of 12.42 billion CNY, a share repurchase totaling 0.4494% of shares for 50.0003 million CNY (highest buy 7.98 CNY, lowest 7.28 CNY), and growth catalysts such as a planned 493 million CNY resin upgrade, a 30,000 tpa resin plant due end-December 2025, and a joint venture in Vietnam projected to add 500 million CNY annually.}

CNSIG Inner Mongolia Chemical Industry Co., Ltd. (600328.SS) - Revenue Analysis

• Quarter (Q3) ending 30 Sep 2025: revenue 2.78 billion CNY, down 13.42% YoY.
• Trailing twelve months (TTM) revenue: 12.10 billion CNY, down 9.83% YoY.
• Full-year 2024 revenue: 12.89 billion CNY, a decline of 20.69% versus 2023.
• Revenue per employee: ~1.33 million CNY (9,087 employees).
• Market capitalization: 12.15 billion CNY; stock price: 8.40 CNY (as of 28 Nov 2025); P/S ratio: 1.00.

• Revenue trend: sequential and annual declines indicate pressure on demand, pricing, or mix; TTM smoothing shows persistent contraction versus prior year.
• Per-employee productivity (~1.33M CNY) provides a benchmark for operational efficiency relative to peers in chemicals and materials.
• P/S of 1.00 with a market cap roughly equal to annual revenue suggests the market is valuing the company at one year of sales-investors should weigh profitability, margin trends, and cash flow versus this top-line valuation.

CNSIG Inner Mongolia Chemical Industry Co., Ltd. (600328.SS) - Profitability Metrics

• Gross profit: 2.06 billion CNY; gross profit margin: 16.02% (YoY decline: 41.54%).
• EBITDA: 2.04 billion CNY; EBITDA margin: 15.85% (YoY decline: 37.32%).
• Operating income: 1.02 billion CNY; operating margin: 7.87% (YoY decline: 54.19%).
• Net income (9 months ending Sep 30, 2025): 57.83 million CNY vs. 573.99 million CNY in same period prior year.
• Basic EPS from continuing operations: 0.0394 CNY vs. 0.3899 CNY prior year.
• TTM net income: 2.64 million CNY; TTM EPS: 0.00 CNY.

• Margin compression across gross, EBITDA, and operating levels indicates either cost pressure, pricing weakness, or a mix shift to lower-margin products.
• The steep YoY drops (41-54%) in margins and a near-collapse in net income for the nine-month period signal heightened operational and/or market headwinds.
• TTM results (net income 2.64 million CNY; EPS 0.00 CNY) underscore how recent losses have eroded annualized profitability despite some positive absolute figures in EBITDA and gross profit.

CNSIG Inner Mongolia Chemical Industry Co., Ltd. (600328.SS) - Debt vs. Equity Structure

Debt-to-equity details are not explicitly disclosed in available sources, but several market-capitalization and enterprise-value figures permit useful inference about the company's capital structure and leverage profile as of March 31, 2025.

• Enterprise Value (EV): 12.42 billion CNY
• Market Capitalization: 11.23 billion CNY
• Implied Net Debt (EV - Market Cap): 1.19 billion CNY
• Price-to-Book (P/B) Ratio: 0.93 - equity valued slightly below book value
• Share buyback completed: 0.4494% of shares repurchased for 50.0003 million CNY (excluding fees)
• Share repurchase price range: highest 7.98 CNY, lowest 7.28 CNY

• Interpretation: the implied net debt of ~1.19 billion CNY indicates leverage exists but is moderate relative to market value; exact debt-to-equity ratio requires explicit balance-sheet debt and shareholders' equity figures.
• Buyback signal: repurchasing 0.4494% at ~50.0 million CNY suggests management is returning capital to shareholders, albeit modestly, while P/B < 1 implies the market sees equity as undervalued versus book.
• Valuation context: investors should reconcile the implied net debt with on‑balance-sheet gross debt and cash to compute a formal debt-to-equity ratio before drawing leverage conclusions.

Further background and corporate context: CNSIG Inner Mongolia Chemical Industry Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

CNSIG Inner Mongolia Chemical Industry Co., Ltd. (600328.SS) - Liquidity and Solvency

CNSIG Inner Mongolia Chemical Industry Co., Ltd. (600328.SS) shows a market presence and solvency profile characterized by modest profitability and relatively low leverage based on enterprise value versus market capitalization.

• Current ratio and quick ratio: not explicitly provided in available sources.
• Market capitalization: 12.15 billion CNY, indicating substantial market presence.
• Enterprise value (EV): 12.42 billion CNY, implying relatively low net debt (EV close to market cap).
• Operating margin (TTM): 7.87%, demonstrating the company's ability to generate operating profit.
• Net income margin (TTM): 3.63%, reflecting overall profitability after expenses and taxes.
• Trailing twelve months (TTM) net income: 2.64 million CNY.
• TTM EPS: 0.00 CNY.

Balance-sheet inference: with EV only marginally above market cap, the company likely carries low net debt or modest leverage; combined with a positive operating margin but a low net income margin and near-zero EPS, this suggests earnings are thin after interest, taxes, depreciation, or one-off items. For broader strategic context and corporate priorities, see: Mission Statement, Vision, & Core Values (2026) of CNSIG Inner Mongolia Chemical Industry Co., Ltd.

CNSIG Inner Mongolia Chemical Industry Co., Ltd. (600328.SS) Valuation Analysis

The following valuation snapshot highlights how the market is pricing CNSIG Inner Mongolia Chemical Industry Co., Ltd. (600328.SS) across common multiples and enterprise metrics. These figures provide a view of current market sentiment, historical earnings impact, and expectations for future profitability.

• Trailing P/E: 4,320.02 - an extremely elevated trailing multiple driven by very low (or possibly negative/one-off) reported earnings in the most recent trailing period.
• Forward P/E: 41.21 - market expects materially higher future earnings versus the trailing period, implying significant earnings recovery or growth is priced in.
• Price-to-Sales (P/S): 1.00 - the stock trades at roughly one times annual revenue, suggesting moderate revenue-based valuation.
• Price-to-Book (P/B): 0.93 - trading slightly below reported book value, indicating the market values the company marginally below its net asset base.
• Enterprise Value / Revenue: 0.97 - EV roughly equals annual revenue, a sign of efficient revenue valuation on an enterprise basis.
• Enterprise Value / EBITDA: 6.43 - a relatively low EV/EBITDA, suggesting an attractive valuation relative to operating cash earnings once adjustments are considered.

Key considerations for investors when reconciling these mixed signals:

• High trailing P/E (4,320.02) likely driven by anomalous trailing earnings; examine annualized and adjusted EPS, non-recurring items, and recent quarter results.
• Forward P/E (41.21) suggests expectations of recovery - verify analyst assumptions, revenue guidance, and margin improvement drivers that support this multiple.
• Close-to-par P/S (1.00) and P/B (0.93) indicate the market isn't assigning large growth premiums to top-line or balance-sheet strength.
• Enterprise multiples (EV/Revenue 0.97; EV/EBITDA 6.43) point to a potentially favorable acquisition-style valuation if operational earnings normalize.
• Perform scenario analyses: stress-test valuation under varying EPS recovery timelines, EBITDA margins, and revenue growth rates.

For broader corporate context and background that can inform valuation assumptions, see: CNSIG Inner Mongolia Chemical Industry Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

CNSIG Inner Mongolia Chemical Industry Co., Ltd. (600328.SS) - Risk Factors

• Highly competitive market: intensified competition in chemicals and petrochemicals can compress selling prices, reduce volumes and erode market share, pressuring top-line growth and margins.
• Regulatory & environmental compliance: stricter emissions, waste handling, and energy-efficiency standards may require capital investment and higher recurring compliance costs, raising operating expenses.
• Raw-material price volatility: inputs such as methanol and other feedstocks have volatile global pricing; increases lead to higher COGS and narrower gross margins if not fully passed to customers.
• Declining operational efficiency: operating margin fell from 15% in 2022 to 12% in 2023, indicating rising operating cost per unit of revenue or less favorable product mix.
• Profitability erosion: net income margin contracted to 3.63% in 2023 from 15% in 2022, and net income dropped from 573.99 million CNY to 57.83 million CNY, signaling significant margin pressure and reduced buffer for shocks.
• Liquidity and leverage sensitivity: lower profitability can strain cash flow coverage of debt and capital expenditures, increasing refinancing and covenant risks in stressed market conditions.

• Price pass-through risk: the company's ability to pass higher raw-material costs to end customers is constrained by market competition and contract structures.
• Capital expenditure burden: investments to meet environmental regulations or efficiency upgrades could raise near-term capex, further pressuring free cash flow and returns.
• Exposure to commodity cycles: downturns in chemical demand or methanol oversupply can materially reduce utilization rates and fixed-cost absorption.
• Operational disruptions: any production halts, plant incidents, or logistic constraints can amplify margin declines given already reduced profitability.

CNSIG Inner Mongolia Chemical Industry Co., Ltd. (600328.SS) - Growth Opportunities

• Capital investment: 493 million CNY allocated to a special resin technology upgrade project to broaden product offerings and improve margins.
• Capacity expansion: Chlor-alkali Company (subsidiary) building an additional 30,000 tpa micro-suspension paste resin line targeted for operation by December 2025.
• International expansion: announced JV with a Vietnamese partner projected to add ~500 million CNY in annual revenue once fully ramped.
• R&D and process innovation: 100 million CNY budgeted for advanced production technologies and innovation in 2023 to raise throughput and lower unit costs.
• Regulatory engagement: proactive compliance efforts intended to reduce permit-related delays and limit fines that could erode profitability.

• Revenue upside: the Vietnamese JV alone could increase consolidated top-line by several percentage points depending on margin realization; projected +500 million CNY p.a.
• Margin expansion: resin technology upgrade and production automation target higher-margin specialty resins and improved gross margin retention.
• Capex timing risk: delays to the 30,000 tpa line or technology upgrade could defer expected revenue and ROI into 2026 or later.
• Commodity input exposure: chlor-alkali feedstock price volatility could compress margins if not hedged or passed through.
• Regulatory risk mitigation: active engagement with regulators reduces legal/closure risk but may increase near-term compliance costs.

• Watch cashflow and leverage metrics as 493 million CNY capex and subsidiary buildouts progress; funding mix will affect balance sheet and interest expense.
• Monitor timing and ramp rates for the 30,000 tpa line and Vietnamese JV revenue recognition to assess realized vs. projected growth.
• Evaluate gross-margin trends post-technology upgrades to confirm specialty resin pricing power and OPEX reductions from the 100 million CNY innovation spend.
• Assess regulatory updates impacting chlor-alkali and resin production; successful engagement reduces tail risk but watch for compliance cost variability.